Literature DB >> 26363467

The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.

Nick W Liu1, James D Wren2, Emily Vertosick3, Justin K Lee2, Nicholas E Power2, Nicole E Benfante2, Simon Y Kimm2, Manjit S Bains4, Daniel D Sjoberg3, Paul Russo2, Jonathan A Coleman2.   

Abstract

PURPOSE: We examined the impact of positive vascular margins in patients with pT3 clear cell renal cell carcinoma.
MATERIALS AND METHODS: After excluding patients with nonvascular positive margins, metastasis, lymph node involvement, neoadjuvant therapy or nonclear cell histology, we identified 224 patients with venous tumor invasion through our institutional database from 1999 to 2013. Kaplan-Meier analysis and log rank tests were used to evaluate whether positive vascular margins were associated with progression-free survival or cancer specific survival.
RESULTS: There were 41 patients (18%) with a positive vascular margin. Margin status was directly related to the level of invasion (p <0.0001). Compared to the negative vascular margin group the positive group had a significantly worse progression-free survival (p=0.01) but not cancer specific survival (p=0.3). Similarly the level of vascular thrombus invasion was significantly associated with worse progression-free survival (p=0.02) but not cancer specific survival (p=0.4). The 3-year progression-free survival was worst with inferior vena cava invasion and best with segmental/muscular venous branch invasion (54%, 95% CI 34-70 vs 76%, 95% CI 64-85). Among patients with only main renal vein thrombus, vascular margin status was not associated with progression-free survival (p=0.5) or cancer specific survival (p=0.2).
CONCLUSIONS: In patients with pT3N0/XM0 clear cell renal cell carcinoma positive vascular margins are associated with risk of disease progression. However, the risk of relapse associated with positive vascular margins is driven by the extent of vascular thrombus invasion. These findings suggest that the clinical significance of vascular margin status as currently defined in pT3 clear cell renal cell carcinoma is minimal.
Copyright © 2016 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  carcinoma, renal cell; kidney neoplasms; neoplasm staging; prognosis; thrombosis

Mesh:

Year:  2015        PMID: 26363467      PMCID: PMC4747821          DOI: 10.1016/j.juro.2015.08.099

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  20 in total

1.  Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases.

Authors:  Andrew Feifer; Caroline Savage; Heidi Rayala; William Lowrance; Geoffrey Gotto; Preston Sprenkle; Amit Gupta; Jennifer Taylor; Melanie Bernstein; Adebowale Adeniran; Satish K Tickoo; Victor E Reuter; Paul Russo
Journal:  J Urol       Date:  2010-11-12       Impact factor: 7.450

2.  Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?

Authors:  Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke; Eugene D Kwon; Igor Frank; R Houston Thompson; Michael L Blute
Journal:  J Urol       Date:  2005-03       Impact factor: 7.450

Review 3.  Epidemiology and risk factors for kidney cancer.

Authors:  Wong-Ho Chow; Linda M Dong; Susan S Devesa
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

4.  Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance.

Authors:  Laurent Zini; Laurence Destrieux-Garnier; Xavier Leroy; Arnauld Villers; Stephan Haulon; Laurent Lemaitre; Mohamad Koussa
Journal:  J Urol       Date:  2008-02       Impact factor: 7.450

5.  Long-term experience with management of renal cell carcinoma involving the inferior vena cava.

Authors:  Nabil K Bissada; Hossam H Yakout; Aga Babanouri; Tarek Elsalamony; Wahib Fahmy; Moustafa Gunham; Gerald W Hull; Uzair B Chaudhary
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

6.  Long-term followup after surgical treatment for renal cell carcinoma extending into the right atrium.

Authors:  A A Glazer; A C Novick
Journal:  J Urol       Date:  1996-02       Impact factor: 7.450

7.  Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?

Authors:  Hyung L Kim; Amnon Zisman; Ken-Ryu Han; Robert A Figlin; Arie S Belldegrun
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

8.  Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same?

Authors:  Alireza Moinzadeh; John A Libertino
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

9.  Solitary floating vena caval thrombus as a late recurrence of renal cell carcinoma.

Authors:  Andrea Minervini; Giuseppe Salinitri; Jacopo Lera; Claudio Caldarelli; Davide Caramella; Riccardo Minervini
Journal:  Int J Urol       Date:  2004-04       Impact factor: 3.369

10.  The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus.

Authors:  Michael L Blute; Bradley C Leibovich; Christine M Lohse; John C Cheville; Horst Zincke
Journal:  BJU Int       Date:  2004-07       Impact factor: 5.588

View more
  5 in total

Review 1.  Surgical Margins in Nephron-Sparing Surgery for Renal Cell Carcinoma.

Authors:  Dean D Laganosky; Christopher P Filson; Viraj A Master
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

2.  Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.

Authors:  Laura R Prakash; Huamin Wang; Jun Zhao; Graciela M Nogueras-Gonzalez; Jordan M Cloyd; Ching-Wei D Tzeng; Michael P Kim; Jeffrey E Lee; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2019-02-28       Impact factor: 3.452

3.  Impact of positive vascular margins status after surgical resection of non-metastatic renal cell carcinoma with caval tumour thrombus: a propensity score multicentre study.

Authors:  Jonathan Olivier; Zine-Eddine Khene; Nicolas Vamour; Anis Gasmi; Xavier Leroy; Philippe Puech; Mohamed Koussa; Arnauld Villers; Jean-Christophe Fantoni; Nicolas Doumerc; Karim Bensalah
Journal:  World J Urol       Date:  2021-11-15       Impact factor: 4.226

Review 4.  Prognostic factors and prognostic models for renal cell carcinoma: a literature review.

Authors:  Tobias Klatte; Sabrina H Rossi; Grant D Stewart
Journal:  World J Urol       Date:  2018-04-30       Impact factor: 4.226

5.  A Predictive Model for Tumor Invasion of the Inferior Vena Cava Wall Using Multimodal Imaging in Patients with Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus.

Authors:  Zhuo Liu; Liwei Li; Peng Hong; Guodong Zhu; Shiying Tang; Xun Zhao; Qiming Zhang; Guoliang Wang; Wei He; Hua Zhang; Heng Xue; Ligang Cui; Huiyu Ge; Jie Jiang; Shudong Zhang; Fangting Cao; Jing Yan; Fengrong Ma; Cheng Liu; Lulin Ma; Shumin Wang
Journal:  Biomed Res Int       Date:  2020-10-06       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.